Selective Histocompatibility Leukocyte Antigen (Hla)-A2 Loss Caused by Aberrant Pre-mRNA Splicing in 624mel28 Melanoma Cells

Histocompatibility leukocyte antigen (HLA)-A2 is used as a restricting element to present several melanoma-associated antigen (MAA)-derived peptides to cytotoxic T lymphocytes (CTLs). HLA-A2 antigen is selectively lost in primary melanoma lesions and more frequently in metastases. Only scanty inform...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhigang, Marincola, Francesco M., Rivoltini, Licia, Parmiani, Giorgio, Ferrone, Soldano
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1999
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195569/
https://www.ncbi.nlm.nih.gov/pubmed/10432284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195569/
https://www.ncbi.nlm.nih.gov/pubmed/10432284

Ejemplares similares